Tonix Pharmaceuticals: Raymond James cuts target price to $26 from $27
TNXP•Raymond James cut its target price for Tonix Pharmaceuticals to $26 from $27.
Related News
FirstService Residential wins property management contract for Boston's Battery Wharf
FSV•
Steel Dynamics publishes update to financial calendar
STLD•
Farmers & Merchants Bank of Long Beach swings to Q3 2026 net loss of $36.78 million
FMBL•
Salesforce agrees to buy Braze for $5.66 billion in enterprise value
CRM•
LiveWire Group showcases expanded product lineup at EICMA
LVWR•